These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24089374)

  • 1. Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice.
    Silva AR; Aguilar EC; Alvarez-Leite JI; da Silva RF; Arantes RM; Bader M; Alenina N; Pelli G; Lenglet S; Galan K; Montecucco F; Mach F; Santos SH; Santos RA
    Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(11):R1323-30. PubMed ID: 24089374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
    Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J
    Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.
    Zhao Y; Yang Y; Xing R; Cui X; Xiao Y; Xie L; You P; Wang T; Zeng L; Peng W; Li D; Chen H; Liu M
    Atherosclerosis; 2018 Apr; 271():26-35. PubMed ID: 29459263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.
    Thomas MC; Pickering RJ; Tsorotes D; Koitka A; Sheehy K; Bernardi S; Toffoli B; Nguyen-Huu TP; Head GA; Fu Y; Chin-Dusting J; Cooper ME; Tikellis C
    Circ Res; 2010 Oct; 107(7):888-97. PubMed ID: 20671240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
    J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice.
    Suski M; Olszanecki R; Stachowicz A; Madej J; Bujak-Giżycka B; Okoń K; Korbut R
    Biochim Biophys Acta; 2013 Dec; 1834(12):2463-9. PubMed ID: 23988828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.
    Yesilaltay A; Daniels K; Pal R; Krieger M; Kocher O
    PLoS One; 2009 Dec; 4(12):e8103. PubMed ID: 19956623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
    Stachowicz A; Wiśniewska A; Kuś K; Białas M; Łomnicka M; Totoń-Żurańska J; Kiepura A; Stachyra K; Suski M; Bujak-Giżycka B; Jawień J; Olszanecki R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development.
    Lammers B; Out R; Hildebrand RB; Quinn CM; Williamson D; Hoekstra M; Meurs I; Van Berkel TJ; Jessup W; Van Eck M
    Atherosclerosis; 2009 Aug; 205(2):420-6. PubMed ID: 19217108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50.
    Fang G; Song D; Ye X; Mao SZ; Liu G; Liu SF
    Am J Pathol; 2012 Nov; 181(5):1530-9. PubMed ID: 22940439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexim1 heterozygosity stabilizes atherosclerotic plaque and decreased steatosis in ApoE null mice fed atherogenic diet.
    Dhar-Mascareno M; Rozenberg I; Iqbal J; Hussain MM; Beckles D; Mascareno E
    Int J Biochem Cell Biol; 2017 Feb; 83():56-64. PubMed ID: 28013147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
    Potthoff SA; Fähling M; Clasen T; Mende S; Ishak B; Suvorava T; Stamer S; Thieme M; Sivritas SH; Kojda G; Patzak A; Rump LC; Stegbauer J
    Hypertension; 2014 Feb; 63(2):265-72. PubMed ID: 24191281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis.
    Cao X; Yang F; Shi T; Yuan M; Xin Z; Xie R; Li S; Li H; Yang JK
    Sci Rep; 2016 Feb; 6():21592. PubMed ID: 26883384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of UCP1 stimulates fatty liver but mediates UCP1-independent action of beige fat to improve hyperlipidemia in Apoe knockout mice.
    Kataoka N; Takeuchi T; Kusudo T; Li Y; Endo Y; Yamashita H
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165762. PubMed ID: 32179129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.
    Jawien J; Toton-Zuranska J; Gajda M; Niepsuj A; Gebska A; Kus K; Suski M; Pyka-Fosciak G; Nowak B; Guzik TJ; Marcinkiewicz J; Olszanecki R; Korbut R
    J Physiol Pharmacol; 2012 Feb; 63(1):77-85. PubMed ID: 22460464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.
    Teng B; Smith JD; Rosenfeld ME; Robinet P; Davis ME; Morrison RR; Mustafa SJ
    Cardiovasc Res; 2014 Apr; 102(1):157-65. PubMed ID: 24525840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia, steatohepatitis and atherogenesis in lipodystrophic apoE deficient mice with Seipin deletion.
    Liao J; Liu X; Gao M; Wang M; Wang Y; Wang F; Huang W; Liu G
    Gene; 2018 Mar; 648():82-88. PubMed ID: 29428127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.